奈克塔制药 NKTR
$37.26 +$1.11 (+3.07%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $37.26 0.00%
开盘$36.58
昨收$36.15
当日区间$36.44 – $37.58
成交量686.4K
市值$1.27B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数12
平均目标价$141.33+279.3% 较现价
- 买入 75%
- 持有 25%
最低 $53.00现价 $37.26均值 $141.33最高 $192.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$53.00至$192.00，平均为$159.11。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 22 Oct 2026 | Piper Sandler | BUY | $192.00 |
| 12 Oct 2026 | UBS | HOLD | $53.00 |
| 12 Oct 2026 | Leerink Partners | BUY | $130.00 |
| 11 Oct 2026 | UBS | HOLD | $53.00 |
| 9 Oct 2026 | BTIG | BUY | $178.00 |
| 8 Oct 2026 | Raymond James | HOLD | – |
| 5 Oct 2026 | Citi | BUY | $151.00 |
| 2 Oct 2026 | H.C. Wainwright | BUY | $185.00 |
| 1 Oct 2026 | William Blair | BUY | – |
| 1 Oct 2026 | Jefferies | BUY | $150.00 |
| 1 Oct 2026 | H.C. Wainwright | BUY | $185.00 |
| 29 Sep 2026 | BTIG | BUY | $178.00 |
| 28 Sep 2026 | CCORF | BUY | $153.00 |
| 25 Sep 2026 | BTIG | BUY | $178.00 |
| 17 Sep 2026 | BTIG | BUY | $178.00 |
| 16 Sep 2026 | BTIG | BUY | $178.00 |
| 20 Aug 2026 | Piper Sandler | BUY | $192.00 |
| 17 Aug 2026 | CCORF | BUY | $153.00 |
| 17 Aug 2026 | H.C. Wainwright | BUY | $185.00 |
| 14 Aug 2026 | Piper Sandler | BUY | $192.00 |
暂无评论——快来第一个聊聊 NKTR。
登录后参与讨论。